Spondyloarthritis & psoriatic arthritis
Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms
Authors' conclusion
Despite treatment, many patients with SpA demonstrate abnormal sleep behaviour with symptoms of insomnia and a reduced quality of life with significant differences between male and female patients.
Study context
- Population
- Treated patients with spondyloarthritides (SpA) (psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA)), monocentric cohort
- Participants
- 330 patients
- Exposure
- Women vs men with SpA; patients with unrestful sleep vs others
- PsAn = 168
- axSpAn = 162
- Outcome
- Sleep quality (Regensburg Insomnia Scale) and quality of life (WHO Quality of Life questionnaire) and associated factors
Methodological detailsquestionnaire-based, retrospective medical chart analysis, monocentric
- Questionnaire-based
- Retrospective medical chart analysis
- Monocentric
Main finding
As reported in the abstract
Abnormal sleep behaviour in patients with SpA
Patients with SpA with abnormal sleep behaviour
46.6%
Observational data: associations, not effects.
Further findings
Unrestful sleep vs restful sleep: health-related quality of life, depressive symptoms, satisfaction with health
- Significantly reduced health-related quality of life with unrestful sleep
- P < 0.001
- Significantly more depressive symptoms with unrestful sleep
- P < 0.001
- Satisfaction with health rated significantly lower with unrestful sleep
- P < 0.001
Women vs men: sleep quality, quality of life and depressive symptoms
- Women: prolonged sleep latency
- P = 0.009
- Women: increased sleep disturbances
- P = 0.014
- Women: unrestful sleep
- P < 0.001
- Women: reduced physical and mental health-related quality of life
- P = 0.015, p<0.001
- Women: more depressive symptoms
- P = 0.015
Original publication
Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms. RMD Open. Published 19 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →